Drug Discovery Technologies

Apr 2021| BIO020G| BCC Publishing
Report Overview

Report Highlights

The global market for drug discovery technologies should grow from $69.8 billion in 2020 to $110.4 billion by 2025 with a compound annual growth rate (CAGR) of 9.6% for the period of 2020-2025.

Report Includes

  • 31 data tables and 16 additional tables
  • An overview of the global market for drug discovery technologies
  • Estimation of the market size and analyses of global market trends, with data from 2019, 2020, and projections of compound annual growth rates (CAGRs) though 2025
  • Evaluation of market forecast, pipeline analysis of new products, regulatory scenarios and detailed analysis of drivers, challenges, and opportunities affecting market growth
  • Market share analysis of drug discovery technologies based on type, application, end-user, and region
  • Information on reverse transcription-polymerase chain reaction (qRT-PCR), and next-generation sequencing (NGS) and coverage of bioanalytical instruments used for drug discovery
  • Information on pharmacokinetics and pharmacodynamics, and classification of techniques used in drug discovery
  • Discussion on bioinformatics as platform for drug discovery and comparison between proteomics and genomics drug discovery technology
  • Detailed description of COVID-19 including symptoms and progression, its effect on medical tourism and insurance providers and coverage of government expenditure on COVID-19
  • Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
  • Comprehensive company profiles of major players of the industry, including Thermo Fisher Scientific, General Electric Co., Agilent, Illumina, Merck KGaA and Bio-Rad Laboratories

Report Scope

In recent years, the drug discovery technologies industry has seen remarkable developments and rapid progress. This report focuses on the global drug discovery technologies market and provides an updated review to include basic design and its applications in different disease areas. The drug discovery technologies include high-throughput screening, bioanalytical instruments, cell-based assays and reagents, genomics, bioinformatics, proteomics, and few others, like combinatorial chemistry, metabolomics, nanotechnology and system biology. These technologies are further classified into subcategories for the purpose of this report. The five main disease application areas described in this report concern different cancer diseases, immunological diseases, neurological diseases, cardiovascular diseases and others, including metabolic, endocrinology and genetic diseases.

The report also covers the market by end-user for drug discovery technologies, segmented into biopharmaceutical companies, research and academia, and contract research organizations (CROs).

This BCC Research report is global in scope and includes an analysis of the various regulatory environments, advancements, new products, market projections and market shares. Also, the report includes relevant patent analysis and comprehensive profiles of companies that lead the drug discovery technologies market. The geographical regions covered are North America, Europe, Asia-Pacific and the Rest of the World. Detailed analyses of major countries such as the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India are covered in regional segments. For market estimates, data is provided for 2019 as the base year, 2020, and forecast through year-end 2025. Projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation.

Analyst Credentials

BCC Publishing Staff comprises expert analysts who are skilled in conducting primary research, secondary research and data analysis and have decades of combined experience covering a wide range of industries, including healthcare, advanced materials and emerging technologies. Collectively, the team represents a diverse set of educational achievements with individual graduate work completed in fields such as microbiology, electrical engineering, business administration and surgery, among others.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesPrice Member Price
Full Report: Drug Discovery Technologies193 $5,500 Free
Chapter- 1: Introduction8Free DownloadFree
Chapter- 2: Summary and Highlights4$250Free
Chapter- 3: Impact of COVID-19 Pandemic10$289Free
Chapter- 4: Market and Technology Background26$753Free
Chapter- 5: Market Breakdown by Technology Type18$521Free
Chapter- 6: Market Breakdown by Disease Application11$318Free
Chapter- 7: Market Breakdown by End-user7$203Free
Chapter- 8: Market Breakdown, by Region26$753Free
Chapter- 9: Industry Structure21$608Free
Chapter- 10: Patent Review/New Developments/Regulatory Aspects21$608Free
Chapter- 11: Analysis of Market Opportunities3$87Free
Chapter- 12: Company Profiles35$1,013Free
Chapter- 13: Appendix: List of Acronyms3$87Free
Published - Feb-2018| Analyst - Shalini Shahani Dewan| Code - BIO020F

Report Highlights

The global market for drug discovery technologies totaled $54.7 billion in 2017. The market should reach $85.8 billion by 2022, growing at a compound annual growth rate (CAGR) of 9.4% during 2017-2022.

Report Includes

  • 60 data tables and 23 additional tables
  • An overview of the global markets for drug discovery technologies
  • Analyses of global market trends with data from 2015, 2016, and 2017, and projections of compound annual growth rates (CAGRs) through 2022
  • A look at the current state of the drug discovery market, existing platforms and products on the market, and detailed analysis of the competitive environment, including new and potential venues for novel technologies and approaches
  • Descriptions of various products, such as bioanalytical instruments, high-throughput screening devices, informatics, and microarrays
  • Analyses of the main positive and negative factors in each sector of the market, potential future trends, and emerging technologies across different segments of the industry
  • Comprehensive company profiles of major players in the market including Agilent Technologies Inc., Ametek Inc., Bayer Technology Services GMBH, Bruker Corp., Compugen Ltd. and GE Healthcare Lifesciences
Published - Feb-2015| Analyst - Shalini Shahani Dewan| Code - BIO020E

Report Highlights

The global market for drug discovery technologies reached nearly $39.5 billion and $46.5 billion in 2013 and 2014, respectively. This market is expected to grow at a compound annual growth rate (CAGR) of 11.3% to nearly $79.5 billion for the period 2014-2019. 

Report Includes

  • An overview of the global markets for drug discovery technologies.
  • Analyses of global market trends, with data from 2012-2014, and projections of CAGRs through 2019.
  • A look at the current state of the drug discovery market, existing platforms and products on the market, and detailed analysis of the competitive environments including new, potential venues for novel technologies and approaches.
  • Descriptions of various products such as bioanalytical instruments, high-throughput screening devices, informatics, and microarrays.
  • Analyses of the main positive and negative factors in each sector of the market, potential future trends, and emerging technologies accross different segments of the industry.
Published - Jun-2012| Analyst - Marianna Tcherpakov| Code - BIO020D

Report Highlights

The global market for drug discovery technologies and products reached $38.4 billion in 2011. It is expected to expand to $41.4 billion in 2012 and to $79.0 billion in 2017, a compound annual growth rate (CAGR) of 13.8% between 2012 and 2017.

Published - Nov-2007| Analyst - Valarie Natale| Code - BIO020C

Report Highlights

  • The global market for drug discovery technologies increased from $20.2 billion in 2006 to an estimated $22 billion in 2007. It should reach $32.5 billion by 2012, a compound annual growth rate (CAGR) of 8.2%.
  • High throughput screening has the largest share of the market, worth an estimated $8.5 billion in 2007, and is expected to reach $12 billion by 2012, a CAGR of 7.1% over the forecast period.
  • While informatics has the smallest share of the market, worth $725 million in 2007, the segment will see the largest CAGR of 15.7%, as its value rises to $1.5 billion by 2012.
Published - Jul-2001| Analyst - Valarie Natale| Code - BIO020B

Report Highlights

REPORT HIGHLIGHTS

  • New methods for drug discovery and delivery are receiving considerable attention in the pharmaceutical industry and in the media. Trial-and-error discovery methods have been replaced by focused combinatorial synthesis, high throughput systems, and other advanced systems. These new methods have produced agents that have entered clinical trials. As a result of the new technologies, costs and development times are falling, and knowledge about each new agent's mode of action has increased.
  • This updated BCC study examines how the new drug discovery technologies have affected costs and drug development times. It also analyzes how new screening technologies, DNA microarrays, and increasingly sophisticated instruments will affect pharmaceutical discovery. An important section of the report analyzes market sizes and market growth for each technology. The report also includes interviews with executives in the instruments industry and the combinatorial chemistry industry.
  • Molecular biology has given scientists detailed knowledge about basic and complex biological processes. One result of this new knowledge has been an explosion in the development of sophisticated pharmaceutical agents. For example, the number of drug candidates that have been screened in the last ten years has increased by three orders of magnitude: in 1990, approximately 500,000 drug compounds were screened; for the year 2000, that number is estimated at 1.5 billion.

Drug Discovery Technologies

Single User License: $5500

Member Price: FREE

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS